Patents by Inventor Margaret B. Van Boldrik

Margaret B. Van Boldrik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Clostridial toxin disease therapy
    Publication number: 20040062771
    Abstract: Treating humans and animals intoxicated with a bacterial toxin by administration of antitoxin. Avian antitoxin in an aqueous solution in therapeutic amount that is orally administrable.
    Type: Application
    Filed: September 15, 2003
    Publication date: April 1, 2004
    Applicant: PROMEGA Corporation
    Inventors: Sean B. Carroll, Margaret B. van Boldrik, Christopher M. Clemens
  • Clostridial toxin disease therapy
    Patent number: 6656468
    Abstract: Treating humans and animals intoxicated with a bacterial toxin by administration of antitoxin. Avian antitoxin in an aqueous solution in therapeutic amount that is orally administrable.
    Type: Grant
    Filed: March 5, 1997
    Date of Patent: December 2, 2003
    Assignee: Promega Corporation
    Inventors: Sean B. Carroll, Margaret B. van Boldrik, Christopher M. Clemens
  • Antitoxins and methods for making antitoxins
    Patent number: 6613326
    Abstract: Effective antitoxins are demonstrated for prophylactic or causal immunotherapy. A method of generating antitoxin composed of highly-pure antibodies is described as an important defense against naturally-occurring plant and/or bacterial toxins.
    Type: Grant
    Filed: September 13, 1994
    Date of Patent: September 2, 2003
    Assignee: Promega Corporation
    Inventors: Sean B. Carroll, Douglas C. Stafford, Margaret B. Van Boldrik
  • Clostridial toxin disease therapy
    Patent number: 5719267
    Abstract: Treating humans and animals intoxicated with a bacterial toxin by administration of antitoxin. Avian antitoxin in an aqueous solution in therapeutic amount that is orally administrable.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: February 17, 1998
    Assignee: Ophidian Pharmaceuticals Inc.
    Inventors: Sean B. Carroll, Margaret B. van Boldrik, Christopher M. Clemens
  • Therapy for clostridial botulinum toxin
    Patent number: 5599539
    Abstract: Treating humans and animals intoxicated with a bacterial toxin by administration of antitoxin. Avian antitoxin in an aqueous solution in therapeutic amount that is orally administrable.
    Type: Grant
    Filed: June 7, 1994
    Date of Patent: February 4, 1997
    Assignee: Ophidian Pharmaceuticals, Inc.
    Inventors: Sean B. Carroll, Margaret B. van Boldrik, Christopher M. Clemens